HRT Financial’s Fusion Pharmaceuticals FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-17,911
Closed -$381K – 3345
2024
Q1
$381K Buy
+17,911
New +$214K ﹤0.01% 1407
2021
Q3
– Sell
-14,180
Closed -$114K – 3896
2021
Q2
$114K Buy
+14,180
New +$122K ﹤0.01% 2565
2020
Q4
– Sell
-10,068
Closed -$121K – 2615
2020
Q3
$121K Buy
+10,068
New +$138K ﹤0.01% 1487

HRT Financial's FUSN Position: Q2 2024 in Review

HRT Financial sold out of Fusion Pharmaceuticals (FUSN) in Q2 2024, closing a stake of 17,911 shares — an estimated $381K sold.

HRT Financial first reported a position in FUSN in Q3 2020 and held it in 3 quarters. The position peaked at $381K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • HRT Financial reported no remaining Fusion Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • HRT Financial sold 17,911 Fusion Pharmaceuticals shares in Q2 2024, an estimated $381K.
  • HRT Financial first reported a position in Fusion Pharmaceuticals in Q3 2020 and held it in 3 quarters.
  • HRT Financial's Fusion Pharmaceuticals position peaked at $381K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals as of Q2 2024.

Based on HRT Financial's 13F filing for Q2 2024, filed 12 Aug 2024.